非薬物療法の介入研究の必須事項
DESCRIPTION
失敗しない研究計画入門TRANSCRIPT
![Page 1: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/1.jpg)
39:
2013/8/24 ( ) 15:30~17:20:
![Page 2: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/2.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 3: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/3.jpg)
��
�
�
�
�
Boutron I et al: Ann Intern Med. 2008 Feb 19;148(4):295-309Moher D et al: BMJ. 2010 Mar 23;340:c869Chan AW et al: BMJ. 2013 Jan 8;346:e7586
![Page 4: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/4.jpg)
� ( )[ ]
1999 8 2004 9
[ ] [ ]
Meyer TD, Hautzinger M: Psychol Med. 2012 Jul;42(7):1429-39.
4
![Page 5: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/5.jpg)
� [ ]
[ ] [ ]
[ ] 6
Boyer L et al: Br J Psychiatry. 2013 Jun;202:447-53
![Page 6: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/6.jpg)
�
8
4
(E.V.)
van Emmerik-van Oortmerssen K et al: BMC Psychiatry. 2013 May 10;13:132.
![Page 7: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/7.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 8: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/8.jpg)
��
•• ( / / )•••
Boutron I et al: Ann Intern Med. 2008 Feb 19;148(4):295-309
/ )
![Page 9: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/9.jpg)
��
•••••
Boutron I et al: Ann Intern Med. 2008 Feb 19;148(4):295-309
![Page 10: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/10.jpg)
Perera R et al: BMJ. 2007 Jan 20;334(7585):127-9
![Page 11: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/11.jpg)
Perera R et al: BMJ. 2007 Jan 20;334(7585):127-9
![Page 12: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/12.jpg)
Perera R et al: BMJ. 2007 Jan 20;334(7585):127-9
a�b
b-c-dc-d
![Page 13: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/13.jpg)
30-40
...( )...
70
Perera R et al: BMJ. 2007 Jan 20;334(7585):127-9
a
b
c
3
.. )...
![Page 14: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/14.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 15: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/15.jpg)
��
�
�
�• /
Moher D et al: BMJ. 2010 Mar 23;340:c869Chan AW et al: BMJ. 2013 Jan 8;346:e7586Calvert M et al: JAMA. 2013 Feb 27;309(8):814-22.
![Page 16: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/16.jpg)
��
• / / /Web�
�• / /
�• /( )
Moher D et al: BMJ. 2010 Mar 23;340:c869Chan AW et al: BMJ. 2013 Jan 8;346:e7586Calvert M et al: JAMA. 2013 Feb 27;309(8):814-22.
![Page 17: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/17.jpg)
� 1� - -
�1�
�
��
�
![Page 18: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/18.jpg)
� 1 [ ]
PTSD�PTSD
[ ] CAPS (Clinician-Administered PTSD Scale) [ ]
Ertl V et al: JAMA. 2011 Aug 3;306(5):503-12.
CAPale) [ ]
![Page 19: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/19.jpg)
� 0.90 0.80
� 0.88 CAPS15
Ertl V et al: JAMA. 2011 Aug 3;306(5):503-12.
.88
![Page 20: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/20.jpg)
� (1 - )[ ]
[ ]
2 t
Ertl V et al: JAMA. 2011 Aug 3;306(5):503-12.
1A 76 50 -26B 80 78 -2
-32.36 -19.32
= 14.06(32.36-19.32)
t
-26-2
![Page 21: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/21.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 22: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/22.jpg)
��
�
) (harm) =
Ioannidis JP et al: Ann Intern Med. 2004 Nov 16;141(10):781-8.
arm) =
![Page 23: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/23.jpg)
� [1]
� [1]
� [1]
� [2]
� [3]
[1] Peterson AL et al: Contemp Clin Trials. 2013 Jan;34(1):152-4[2] Berk M, Parker G: Aust N Z J Psychiatry. 2009 Sep;43(9):787-94[3] Nutt DJ, Sharpe M: J Psychopharmacol. 2008 Jan;22(1):3-6
1
3
![Page 24: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/24.jpg)
1
Horigian VE et al: Clin Trials. 2010 Feb;7(1):58-68.
![Page 25: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/25.jpg)
�
�
�� (CDSS)
2 (0~3 )�
� (CGI) 2 6 (0~7 )
Klingberg S et al: J Nerv Ment Dis. 2012 Jul;200(7):569-76
(C(0~3
![Page 26: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/26.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 27: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/27.jpg)
��
• UMIN Clinical Trials Registry• ClinicalTrials.gov
�
) (Clinical Trial) = 1
Moher D et al: BMJ. 2010 Mar 23;340:c869Chan AW et al: BMJ. 2013 Jan 8;346:e7586
gistry
(Clinica
![Page 28: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/28.jpg)
� (4 min)� (6 min)� (6 min)� (4 min)� (4 min)� (6 min)
(6 mi(6 mi
(4 m(
![Page 29: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/29.jpg)
1++ RCTRCT
1+ , RCT, RCT
1- , RCT , RCT
2++
2+2-34
AHRQ: http://www.guideline.gov/content.aspx?id=39324
![Page 30: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/30.jpg)
A 1 1++1+
B 2++1++ 1+
C 2+2++
D 3 42+
GPP
AHRQ: http://www.guideline.gov/content.aspx?id=39324
![Page 31: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/31.jpg)
�4~6� � 2+ ( )� : C
AHRQ: http://www.guideline.gov/content.aspx?id=39324
![Page 32: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/32.jpg)
� 1
� � 4 ( )� : D
AHRQ: http://www.guideline.gov/content.aspx?id=39324
![Page 33: 非薬物療法の介入研究の必須事項](https://reader035.vdocuments.us/reader035/viewer/2022062607/55494b80b4c905054d8b58f8/html5/thumbnails/33.jpg)
�
�
�
�
�
�